- Home
- SURG vs ADAP Comparison
SURG vs ADAP Comparison
Compare SURG & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ADAP
- Stock Information
- Founded
- SURG 2006
- ADAP 2008
- Country
- SURG United States
- ADAP United Kingdom
- Employees
- SURG N/A
- ADAP N/A
- Industry
- SURG Advertising
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- ADAP Health Care
- Exchange
- SURG Nasdaq
- ADAP Nasdaq
- Market Cap
- SURG 64.1M
- ADAP 75.5M
- IPO Year
- SURG N/A
- ADAP 2015
- Fundamental
- Price
- SURG $2.94
- ADAP $0.35
- Analyst Decision
- SURG Strong Buy
- ADAP Buy
- Analyst Count
- SURG 1
- ADAP 6
- Target Price
- SURG $9.00
- ADAP $1.35
- AVG Volume (30 Days)
- SURG 68.8K
- ADAP 745.6K
- Earning Date
- SURG 08-12-2025
- ADAP 08-11-2025
- Dividend Yield
- SURG N/A
- ADAP N/A
- EPS Growth
- SURG N/A
- ADAP N/A
- EPS
- SURG N/A
- ADAP N/A
- Revenue
- SURG $40,029,467.00
- ADAP $179,639,000.00
- Revenue This Year
- SURG $57.76
- ADAP N/A
- Revenue Next Year
- SURG $112.61
- ADAP $37.22
- P/E Ratio
- SURG N/A
- ADAP N/A
- Revenue Growth
- SURG N/A
- ADAP 878.53
- 52 Week Low
- SURG $1.05
- ADAP $0.20
- 52 Week High
- SURG $3.47
- ADAP $1.48
- Technical
- Relative Strength Index (RSI)
- SURG 46.76
- ADAP 75.18
- Support Level
- SURG $2.86
- ADAP $0.27
- Resistance Level
- SURG $3.13
- ADAP $0.36
- Average True Range (ATR)
- SURG 0.15
- ADAP 0.02
- MACD
- SURG -0.02
- ADAP 0.01
- Stochastic Oscillator
- SURG 13.56
- ADAP 90.51
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.